Lead Product(s) : Fospropofol
Therapeutic Area : Neurology
Study Phase : Phase IV
Sponsor : Eisai Inc
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Fospropofol is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Pain.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
July 25, 2011
Lead Product(s) : Fospropofol
Therapeutic Area : Neurology
Highest Development Status : Phase IV
Sponsor : Eisai Inc
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Fospropofol
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Lusedra is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
March 07, 2011
Lead Product(s) : Fospropofol
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Fospropofol
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Lusedra is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
March 04, 2011
Lead Product(s) : Fospropofol
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Fospropofol
Therapeutic Area : Pulmonary/Respiratory Diseases
Study Phase : Undisclosed
Sponsor : Eisai Inc
Deal Size : Inapplicable
Deal Type : Inapplicable
Fospropofol for Sedation During Elective Awake Intubation
Details : Fospropofol is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Pulmonary Disease, Chronic Obstructive.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
February 03, 2011
Lead Product(s) : Fospropofol
Therapeutic Area : Pulmonary/Respiratory Diseases
Highest Development Status : Undisclosed
Sponsor : Eisai Inc
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Fospropofol
Therapeutic Area : Undisclosed
Study Phase : Phase IV
Sponsor : Eisai Inc
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Fospropofol disodium is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
September 03, 2010
Lead Product(s) : Fospropofol
Therapeutic Area : Undisclosed
Highest Development Status : Phase IV
Sponsor : Eisai Inc
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Fospropofol
Therapeutic Area : Undisclosed
Study Phase : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Fospropofol disodium is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
May 20, 2010
Lead Product(s) : Fospropofol
Therapeutic Area : Undisclosed
Highest Development Status : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
